{"took":180,"timed_out":false,"_shards":{"total":50,"successful":50,"skipped":0,"failed":0},"hits":{"total":{"value":127,"relation":"eq"},"max_score":33.79203,"hits":[{"_index":"edgar_file","_id":"0001213900-21-013393:ea136999ex99-1_biondvax.htm","_score":33.79203,"_source":{"ciks":["0001611747"],"period_ending":"2021-03-04","file_num":["001-37353"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":2,"root_forms":["6-K"],"file_date":"2021-03-04","biz_states":["L3"],"sics":["2836"],"form":"6-K","adsh":"0001213900-21-013393","film_num":["21713258"],"biz_locations":["Jerusalem, L3"],"file_type":"EX-99.1","file_description":"NOTICE AND PROXY STATEMENT","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-20-000828:f6k0120bex99-1_biondvax.htm","_score":33.76404,"_source":{"ciks":["0001611747"],"period_ending":"2020-01-13","file_num":["001-37353"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":2,"root_forms":["6-K"],"file_date":"2020-01-13","biz_states":["L3"],"sics":["2836"],"form":"6-K","adsh":"0001213900-20-000828","film_num":["20522680"],"biz_locations":["Nes-ziona, L3"],"file_type":"EX-99.1","file_description":"NOTICE AND PROXY STATEMENT","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-20-004711:ea119006ex99-1_biondvax.htm","_score":33.54111,"_source":{"ciks":["0001611747"],"period_ending":"2020-02-25","file_num":["001-37353"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":2,"root_forms":["6-K"],"file_date":"2020-02-25","biz_states":["L3"],"sics":["2836"],"form":"6-K","adsh":"0001213900-20-004711","film_num":["20649174"],"biz_locations":["Nes-ziona, L3"],"file_type":"EX-99.1","file_description":"NOTICE AND PROXY STATEMENT","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-21-011399:ea136416ex99-1_biond.htm","_score":32.742035,"_source":{"ciks":["0001611747"],"period_ending":"2021-02-24","file_num":["001-37353"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":2,"root_forms":["6-K"],"file_date":"2021-02-24","biz_states":["L3"],"sics":["2836"],"form":"6-K","adsh":"0001213900-21-011399","film_num":["21674354"],"biz_locations":["Jerusalem, L3"],"file_type":"EX-99.1","file_description":"NOTICE OF EXTRAORDINARY MEETING OF SHAREHOLDERS","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-21-010105:ea135920ex99-1_biondvax.htm","_score":32.338615,"_source":{"ciks":["0001611747"],"period_ending":"2021-02-17","file_num":["001-37353"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":2,"root_forms":["6-K"],"file_date":"2021-02-17","biz_states":["L3"],"sics":["2836"],"form":"6-K","adsh":"0001213900-21-010105","film_num":["21645485"],"biz_locations":["Jerusalem, L3"],"file_type":"EX-99.1","file_description":"NOTICE OF EXTRAORDINARY MEETING OF SHAREHOLDERS","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-18-011431:f6k082018b_biondvaxpharma.htm","_score":31.523663,"_source":{"ciks":["0001611747"],"period_ending":"2018-08-20","file_num":["001-37353"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":1,"root_forms":["6-K"],"file_date":"2018-08-20","biz_states":["L3"],"sics":["2836"],"form":"6-K","adsh":"0001213900-18-011431","film_num":["181028302"],"biz_locations":["Nes-ziona, L3"],"file_type":"6-K","file_description":"REPORT OF FOREIGN PRIVATE ISSUER","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-20-020357:ea125062ex99-1_biondvax.htm","_score":31.08759,"_source":{"ciks":["0001611747"],"period_ending":"2020-08-05","file_num":["001-37353"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":2,"root_forms":["6-K"],"file_date":"2020-08-05","biz_states":["L3"],"sics":["2836"],"form":"6-K","adsh":"0001213900-20-020357","film_num":["201076644"],"biz_locations":["Nes-ziona, L3"],"file_type":"EX-99.1","file_description":"NOTICE AND PROXY STATEMENT","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-25-110087:ea026558701ex99-1_scinai.htm","_score":30.86655,"_source":{"ciks":["0001611747"],"period_ending":"2025-11-13","file_num":["001-37353"],"display_names":["Scinai Immunotherapeutics Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":2,"root_forms":["6-K"],"file_date":"2025-11-13","biz_states":["L3"],"sics":["2836"],"form":"6-K","adsh":"0001213900-25-110087","film_num":["251479480"],"biz_locations":["Jerusalem, L3"],"file_type":"EX-99.1","file_description":"NOTICE AND PROXY STATEMENT OF ANNUAL GENERAL MEETING OF SHAREHOLDERS","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-23-070619:ea184177-6k_biondvax.htm","_score":30.46368,"_source":{"ciks":["0001611747"],"period_ending":"2023-08-24","file_num":["001-37353"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":1,"root_forms":["6-K"],"file_date":"2023-08-24","biz_states":["L3"],"sics":["2836"],"form":"6-K","adsh":"0001213900-23-070619","film_num":["231202166"],"biz_locations":["Jerusalem, L3"],"file_type":"6-K","file_description":"REPORT OF FOREIGN PRIVATE ISSUER","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-19-027267:f6k123119ex99-1_biond.htm","_score":30.405708,"_source":{"ciks":["0001611747"],"period_ending":"2019-12-31","file_num":["001-37353"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":2,"root_forms":["6-K"],"file_date":"2019-12-31","biz_states":["L3"],"sics":["2836"],"form":"6-K","adsh":"0001213900-19-027267","film_num":["191319101"],"biz_locations":["Nes-ziona, L3"],"file_type":"EX-99.1","file_description":"NOTICE OF ANNUAL GENERAL MEETING","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-25-125287:ea0270793-6k_scinai.htm","_score":30.351755,"_source":{"ciks":["0001611747"],"period_ending":"2025-12-23","file_num":["001-37353"],"display_names":["Scinai Immunotherapeutics Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":1,"root_forms":["6-K"],"file_date":"2025-12-23","biz_states":["L3"],"sics":["2836"],"form":"6-K","adsh":"0001213900-25-125287","film_num":["251600412"],"biz_locations":["Jerusalem, L3"],"file_type":"6-K","file_description":"REPORT OF FOREIGN PRIVATE ISSUER","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-20-003063:f6k021020ex99-1_biondvax.htm","_score":30.124985,"_source":{"ciks":["0001611747"],"period_ending":"2020-02-10","file_num":["001-37353"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":2,"root_forms":["6-K"],"file_date":"2020-02-10","biz_states":["L3"],"sics":["2836"],"form":"6-K","adsh":"0001213900-20-003063","film_num":["20590264"],"biz_locations":["Nes-ziona, L3"],"file_type":"EX-99.1","file_description":"NOTICE OF ANNUAL GENERAL MEETING","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-20-003126:f6k021020a1ex99-1_biondvax.htm","_score":30.036558,"_source":{"ciks":["0001611747"],"period_ending":"2020-02-10","file_num":["001-37353"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":2,"root_forms":["6-K"],"file_date":"2020-02-10","biz_states":["L3"],"sics":["2836"],"form":"6-K/A","adsh":"0001213900-20-003126","film_num":["20593023"],"biz_locations":["Nes-ziona, L3"],"file_type":"EX-99.1","file_description":"NOTICE OF ANNUAL GENERAL MEETING","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-14-009164:ff12014ex10xi_biondvax.htm","_score":29.847647,"_source":{"ciks":["0001611747"],"period_ending":null,"file_num":["333-201283"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":14,"root_forms":["F-1"],"file_date":"2014-12-29","biz_states":["L3"],"sics":["2836"],"form":"F-1","adsh":"0001213900-14-009164","film_num":["141313416"],"biz_locations":["Nes-ziona, L3"],"file_type":"EX-10.11","file_description":"ADDENDUM TO EMPLOYMENT AGREEMENT DATED APRIL 1, 2012, BETWEEN BIONDVAX PHARMACEUTICALS LTD. AND DR. TAMAR BEN YEDIDIA.","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-21-016926:ea138186ex99-1_biondvax.htm","_score":29.80989,"_source":{"ciks":["0001611747"],"period_ending":"2021-03-22","file_num":["001-37353"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":2,"root_forms":["6-K"],"file_date":"2021-03-22","biz_states":["L3"],"sics":["2836"],"form":"6-K","adsh":"0001213900-21-016926","film_num":["21761248"],"biz_locations":["Jerusalem, L3"],"file_type":"EX-99.1","file_description":"CORPORATE PRESENTATION","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-23-056423:ea181678ex99-1_biondvax.htm","_score":29.79572,"_source":{"ciks":["0001611747"],"period_ending":"2023-07-12","file_num":["001-37353"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":2,"root_forms":["6-K"],"file_date":"2023-07-12","biz_states":["L3"],"sics":["2836"],"form":"6-K","adsh":"0001213900-23-056423","film_num":["231084077"],"biz_locations":["Jerusalem, L3"],"file_type":"EX-99.1","file_description":"NOTICE AND PROXY STATEMENT","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001019155-15-000136:bioa425024f6.htm","_score":29.489656,"_source":{"ciks":["0001611747","0001201935"],"period_ending":null,"file_num":["333-203333"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)","BANK OF NEW YORK / ADR DIVISION  (CIK 0001201935)"],"xsl":null,"sequence":1,"root_forms":["F-6"],"file_date":"2015-04-10","biz_states":["L3","NY"],"sics":["2836","8880"],"form":"F-6","adsh":"0001019155-15-000136","film_num":["15763728"],"biz_locations":["Nes-ziona, L3","Nyc, NY"],"file_type":"F-6","file_description":"FORM F-6","inc_states":["L3","NY"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-18-006949:f6k052918ex99-2_biondvax.htm","_score":29.433777,"_source":{"ciks":["0001611747"],"period_ending":"2018-05-29","file_num":["001-37353"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":3,"root_forms":["6-K"],"file_date":"2018-05-29","biz_states":["L3"],"sics":["2836"],"form":"6-K","adsh":"0001213900-18-006949","film_num":["18864408"],"biz_locations":["Nes-ziona, L3"],"file_type":"EX-99.2","file_description":"BIONDVAX PHARMACEUTICALS LTD. UNAUDITED FINANCIAL STATEMENTS FOR THE PERIOD ENDED MARCH 31, 2018","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-15-004570:f6k061815_biondvaxpharma.htm","_score":29.244053,"_source":{"ciks":["0001611747"],"period_ending":"2015-06-19","file_num":["001-37353"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":1,"root_forms":["6-K"],"file_date":"2015-06-19","biz_states":["L3"],"sics":["2836"],"form":"6-K","adsh":"0001213900-15-004570","film_num":["15941358"],"biz_locations":["Nes-ziona, L3"],"file_type":"6-K","file_description":"REPORT OF FOREIGN PRIVATE ISSUER","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001406071-12-000001:primary_doc.xml","_score":28.736351,"_source":{"ciks":["0001406071"],"period_ending":null,"file_num":["021-179972"],"display_names":["IZUN PHARMACEUTICALS CORP  (CIK 0001406071)"],"xsl":"xslFormDX01","schema_version":"X0705","sequence":1,"root_forms":["D"],"file_date":"2012-06-19","biz_states":["L3"],"sics":[],"form":"D","adsh":"0001406071-12-000001","film_num":["12914850"],"biz_locations":["Jerusalem, L3"],"file_type":"D","file_description":null,"inc_states":["DE"],"items":["06"]}},{"_index":"edgar_file","_id":"0001213900-18-011551:f6k082218bex99-2_biondvax.htm","_score":28.422432,"_source":{"ciks":["0001611747"],"period_ending":"2018-08-22","file_num":["001-37353"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":3,"root_forms":["6-K"],"file_date":"2018-08-22","biz_states":["L3"],"sics":["2836"],"form":"6-K","adsh":"0001213900-18-011551","film_num":["181031423"],"biz_locations":["Nes-ziona, L3"],"file_type":"EX-99.2","file_description":"BIONDVAX PHARMACEUTICALS LTD. UNAUDITED FINANCIAL STATEMENTS FOR THE PERIOD ENDED JUNE 30, 2018","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-18-002208:f6k022218b_biondvaxpharma.htm","_score":28.246994,"_source":{"ciks":["0001611747"],"period_ending":"2018-02-22","file_num":["001-37353"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":1,"root_forms":["6-K"],"file_date":"2018-02-22","biz_states":["L3"],"sics":["2836"],"form":"6-K","adsh":"0001213900-18-002208","film_num":["18632473"],"biz_locations":["Nes-ziona, L3"],"file_type":"6-K","file_description":"REPORT OF FOREIGN PRIVATE ISSUER","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-23-000329:ownership.xml","_score":28.0127,"_source":{"ciks":["0001960174","0001611747"],"period_ending":"2023-01-01","file_num":["001-37353"],"display_names":["Rotman Avner  (CIK 0001960174)","BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":"xslF345X02","schema_version":"X0206","sequence":1,"root_forms":["3"],"file_date":"2023-01-03","biz_states":["L3"],"sics":["2836"],"form":"3","adsh":"0001213900-23-000329","film_num":["23501758"],"biz_locations":["","Jerusalem, L3"],"file_type":"3","file_description":null,"inc_states":["","L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-23-030288:ea176534-s8_biondvaxpharma.htm","_score":27.921055,"_source":{"ciks":["0001611747"],"period_ending":null,"file_num":["333-271293"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":1,"root_forms":["S-8"],"file_date":"2023-04-17","biz_states":["L3"],"sics":["2836"],"form":"S-8","adsh":"0001213900-23-030288","film_num":["23824522"],"biz_locations":["Jerusalem, L3"],"file_type":"S-8","file_description":"REGISTRATION STATEMENT","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-23-004276:ownership.xml","_score":27.912811,"_source":{"ciks":["0001960174","0001611747"],"period_ending":"2023-01-01","file_num":["001-37353"],"display_names":["Rotman Avner  (CIK 0001960174)","BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":"xslF345X02","schema_version":"X0206","sequence":1,"root_forms":["3"],"file_date":"2023-01-23","biz_states":["L3"],"sics":["2836"],"form":"3/A","adsh":"0001213900-23-004276","film_num":["23542538"],"biz_locations":["","Jerusalem, L3"],"file_type":"3/A","file_description":null,"inc_states":["","L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-19-012180:f6k070819_biondvax.htm","_score":27.731226,"_source":{"ciks":["0001611747"],"period_ending":"2019-07-08","file_num":["001-37353"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":1,"root_forms":["6-K"],"file_date":"2019-07-08","biz_states":["L3"],"sics":["2836"],"form":"6-K","adsh":"0001213900-19-012180","film_num":["19944220"],"biz_locations":["Nes-ziona, L3"],"file_type":"6-K","file_description":"CURRENT REPORT OF FOREIGN ISSUER","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-19-002756:f6k021819_biondvax.htm","_score":27.681416,"_source":{"ciks":["0001611747"],"period_ending":"2019-02-18","file_num":["001-37353"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":1,"root_forms":["6-K"],"file_date":"2019-02-19","biz_states":["L3"],"sics":["2836"],"form":"6-K","adsh":"0001213900-19-002756","film_num":["19613372"],"biz_locations":["Nes-ziona, L3"],"file_type":"6-K","file_description":"REPORT OF FOREIGN PRIVATE ISSUER","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001013762-23-000857:primary_doc.xml","_score":27.600018,"_source":{"ciks":["0001611747"],"period_ending":null,"file_num":["021-493666"],"display_names":["Scinai Immunotherapeutics Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":"xslFormDX01","schema_version":"X0708","sequence":1,"root_forms":["D"],"file_date":"2023-10-03","biz_states":["L3"],"sics":["2836"],"form":"D","adsh":"0001013762-23-000857","film_num":["231302307"],"biz_locations":["Jerusalem, L3"],"file_type":"D","file_description":null,"inc_states":["L3"],"items":["06B"]}},{"_index":"edgar_file","_id":"0001213900-25-109050:ea0264993-s8_scinai.htm","_score":27.512691,"_source":{"ciks":["0001611747"],"period_ending":null,"file_num":["333-291460"],"display_names":["Scinai Immunotherapeutics Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":1,"root_forms":["S-8"],"file_date":"2025-11-12","biz_states":["L3"],"sics":["2836"],"form":"S-8","adsh":"0001213900-25-109050","film_num":["251471475"],"biz_locations":["Jerusalem, L3"],"file_type":"S-8","file_description":"REGISTRATION STATEMENT","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-24-003112:primary_doc.xml","_score":27.314936,"_source":{"ciks":["0001611747"],"period_ending":null,"file_num":["021-502265"],"display_names":["Scinai Immunotherapeutics Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":"xslFormDX01","schema_version":"X0708","sequence":1,"root_forms":["D"],"file_date":"2024-01-12","biz_states":["L3"],"sics":["2836"],"form":"D","adsh":"0001213900-24-003112","film_num":["24530585"],"biz_locations":["Jerusalem, L3"],"file_type":"D","file_description":null,"inc_states":["L3"],"items":["06B"]}},{"_index":"edgar_file","_id":"0001213900-15-005544:f6k073015_biondvaxphar.htm","_score":27.065002,"_source":{"ciks":["0001611747"],"period_ending":"2015-07-30","file_num":["001-37353"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":1,"root_forms":["6-K"],"file_date":"2015-07-30","biz_states":["L3"],"sics":["2836"],"form":"6-K","adsh":"0001213900-15-005544","film_num":["151014303"],"biz_locations":["Nes-ziona, L3"],"file_type":"6-K","file_description":"REPORT OF FOREIGN PRIVATE ISSUER","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-20-015429:ea123060-s8_biondvaxpharma.htm","_score":27.060389,"_source":{"ciks":["0001611747"],"period_ending":null,"file_num":["333-239344"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":1,"root_forms":["S-8"],"file_date":"2020-06-22","biz_states":["L3"],"sics":["2836"],"form":"S-8","adsh":"0001213900-20-015429","film_num":["20978080"],"biz_locations":["Nes-ziona, L3"],"file_type":"S-8","file_description":"REGISTRATION STATEMENT","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-17-009314:f6k083017_biondvaxpharma.htm","_score":26.99367,"_source":{"ciks":["0001611747"],"period_ending":"2017-08-31","file_num":["001-37353"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":1,"root_forms":["6-K"],"file_date":"2017-08-31","biz_states":["L3"],"sics":["2836"],"form":"6-K","adsh":"0001213900-17-009314","film_num":["171062069"],"biz_locations":["Nes-ziona, L3"],"file_type":"6-K","file_description":"REPORT OF FOREIGN PRIVATE ISSUER","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-15-004224:f6k060115_biondvax.htm","_score":26.848457,"_source":{"ciks":["0001611747"],"period_ending":"2015-06-01","file_num":["001-37353"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":1,"root_forms":["6-K"],"file_date":"2015-06-01","biz_states":["L3"],"sics":["2836"],"form":"6-K","adsh":"0001213900-15-004224","film_num":["15901199"],"biz_locations":["Nes-ziona, L3"],"file_type":"6-K","file_description":"REPORT OF FOREIGN PRIVATE ISSUER","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-17-009314:f6k083017ex99-3_biondvax.htm","_score":26.5836,"_source":{"ciks":["0001611747"],"period_ending":"2017-08-31","file_num":["001-37353"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":4,"root_forms":["6-K"],"file_date":"2017-08-31","biz_states":["L3"],"sics":["2836"],"form":"6-K","adsh":"0001213900-17-009314","film_num":["171062069"],"biz_locations":["Nes-ziona, L3"],"file_type":"EX-99.3","file_description":"PRESS RELEASE ON DELISTING AND APPOINTMENT OF A COMMITTEE, DATED AUGUST 31, 2017.","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-23-054352:ea181327ex99-1_biondvax.htm","_score":26.51478,"_source":{"ciks":["0001611747"],"period_ending":"2023-07-05","file_num":["001-37353"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":2,"root_forms":["6-K"],"file_date":"2023-07-05","biz_states":["L3"],"sics":["2836"],"form":"6-K","adsh":"0001213900-23-054352","film_num":["231066842"],"biz_locations":["Jerusalem, L3"],"file_type":"EX-99.1","file_description":"NOTICE OF 2023 ANNUAL GENERAL MEETING OF SHAREHOLDERS","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-25-110052:ea0265488-6k_scinai.htm","_score":26.45697,"_source":{"ciks":["0001611747"],"period_ending":"2025-11-13","file_num":["001-37353"],"display_names":["Scinai Immunotherapeutics Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":1,"root_forms":["6-K"],"file_date":"2025-11-13","biz_states":["L3"],"sics":["2836"],"form":"6-K","adsh":"0001213900-25-110052","film_num":["251479209"],"biz_locations":["Jerusalem, L3"],"file_type":"6-K","file_description":"REPORT OF FOREIGN PRIVATE ISSUER","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-15-006485:f6k082415_biondvaxpharma.htm","_score":25.75098,"_source":{"ciks":["0001611747"],"period_ending":"2015-08-24","file_num":["001-37353"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":1,"root_forms":["6-K"],"file_date":"2015-08-24","biz_states":["L3"],"sics":["2836"],"form":"6-K","adsh":"0001213900-15-006485","film_num":["151069966"],"biz_locations":["Nes-ziona, L3"],"file_type":"6-K","file_description":"REPORT OF FOREIGN PRIVATE ISSUER","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-20-018857:ea124583ex99-1_biondvax.htm","_score":25.63672,"_source":{"ciks":["0001611747"],"period_ending":"2020-07-28","file_num":["001-37353"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":2,"root_forms":["6-K"],"file_date":"2020-07-28","biz_states":["L3"],"sics":["2836"],"form":"6-K","adsh":"0001213900-20-018857","film_num":["201053476"],"biz_locations":["Nes-ziona, L3"],"file_type":"EX-99.1","file_description":"NOTICE OF ANNUAL GENERAL MEETING","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-16-019019:ff32016a1_biondvaxpharma.htm","_score":25.132477,"_source":{"ciks":["0001611747"],"period_ending":null,"file_num":["333-214439"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":1,"root_forms":["F-3"],"file_date":"2016-11-29","biz_states":["L3"],"sics":["2836"],"form":"F-3/A","adsh":"0001213900-16-019019","film_num":["162023083"],"biz_locations":["Nes-ziona, L3"],"file_type":"F-3/A","file_description":"PRE-EFFECTIVE AMENDMENT NO. 1 TO FORM F-3","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-19-016840:f6k082819ex99-1_biondvax.htm","_score":24.607107,"_source":{"ciks":["0001611747"],"period_ending":"2019-08-28","file_num":["001-37353"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":2,"root_forms":["6-K"],"file_date":"2019-08-28","biz_states":["L3"],"sics":["2836"],"form":"6-K","adsh":"0001213900-19-016840","film_num":["191059578"],"biz_locations":["Nes-ziona, L3"],"file_type":"EX-99.1","file_description":"PRESS RELEASE DATED AUGUST 28, 2019","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-15-003151:ff12015a4_biondvax.htm","_score":24.440138,"_source":{"ciks":["0001611747"],"period_ending":null,"file_num":["333-201283"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":1,"root_forms":["F-1"],"file_date":"2015-04-30","biz_states":["L3"],"sics":["2836"],"form":"F-1/A","adsh":"0001213900-15-003151","film_num":["15816615"],"biz_locations":["Nes-ziona, L3"],"file_type":"F-1/A","file_description":"REGISTRATION STATEMENT TO AMENDMENT NO. 4","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-22-001450:ea153774ex99-1_biondvax.htm","_score":23.807415,"_source":{"ciks":["0001611747"],"period_ending":"2022-01-10","file_num":["001-37353"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":2,"root_forms":["6-K"],"file_date":"2022-01-11","biz_states":["L3"],"sics":["2836"],"form":"6-K","adsh":"0001213900-22-001450","film_num":["22522662"],"biz_locations":["Jerusalem, L3"],"file_type":"EX-99.1","file_description":"BIONDVAX PRESENTATION DATED JANUARY 2022","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-23-002123:ea171484ex99-1_biondvax.htm","_score":23.007221,"_source":{"ciks":["0001611747"],"period_ending":"2023-01-11","file_num":["001-37353"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":2,"root_forms":["6-K"],"file_date":"2023-01-11","biz_states":["L3"],"sics":["2836"],"form":"6-K","adsh":"0001213900-23-002123","film_num":["23522510"],"biz_locations":["Jerusalem, L3"],"file_type":"EX-99.1","file_description":"BIONDVAX PRESENTATION DATED JANUARY 2023","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-17-009314:f6k083017ex99-2_biondvax.htm","_score":22.977184,"_source":{"ciks":["0001611747"],"period_ending":"2017-08-31","file_num":["001-37353"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":3,"root_forms":["6-K"],"file_date":"2017-08-31","biz_states":["L3"],"sics":["2836"],"form":"6-K","adsh":"0001213900-17-009314","film_num":["171062069"],"biz_locations":["Nes-ziona, L3"],"file_type":"EX-99.2","file_description":"BIONDVAX PHARMACEUTICALS LTD. UNAUDITED FINANCIAL STATEMENTS FOR THE PERIOD ENDED JUNE 30, 2017","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-22-083391:ea170933ex99-1_biondvax.htm","_score":22.870897,"_source":{"ciks":["0001611747"],"period_ending":"2022-12-29","file_num":["001-37353"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":2,"root_forms":["6-K"],"file_date":"2022-12-29","biz_states":["L3"],"sics":["2836"],"form":"6-K","adsh":"0001213900-22-083391","film_num":["221497045"],"biz_locations":["Jerusalem, L3"],"file_type":"EX-99.1","file_description":"BIONDVAX PRESENTATION DATED JANUARY, 2023","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-18-015622:f6k111418ex99-2_biondva.htm","_score":22.55576,"_source":{"ciks":["0001611747"],"period_ending":"2018-11-14","file_num":["001-37353"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":3,"root_forms":["6-K"],"file_date":"2018-11-14","biz_states":["L3"],"sics":["2836"],"form":"6-K","adsh":"0001213900-18-015622","film_num":["181180430"],"biz_locations":["Nes-ziona, L3"],"file_type":"EX-99.2","file_description":"BIONDVAX PHARMACEUTICALS LTD. UNAUDITED FINANCIAL STATEMENTS FOR THE PERIOD ENDED SEPTEMBER 30, 2018","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-23-070064:ea184106ex99-1_biondvax.htm","_score":22.434217,"_source":{"ciks":["0001611747"],"period_ending":"2023-08-23","file_num":["001-37353"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":2,"root_forms":["6-K"],"file_date":"2023-08-23","biz_states":["L3"],"sics":["2836"],"form":"6-K","adsh":"0001213900-23-070064","film_num":["231195088"],"biz_locations":["Jerusalem, L3"],"file_type":"EX-99.1","file_description":"BIONDVAX PRESENTATION, DATED AUGUST 2023","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-19-006913:f6k042219bex99-1_biondvax.htm","_score":21.948956,"_source":{"ciks":["0001611747"],"period_ending":"2019-04-23","file_num":["001-37353"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":2,"root_forms":["6-K"],"file_date":"2019-04-23","biz_states":["L3"],"sics":["2836"],"form":"6-K","adsh":"0001213900-19-006913","film_num":["19760596"],"biz_locations":["Nes-ziona, L3"],"file_type":"EX-99.1","file_description":"NOTICE AND PROXY STATEMENT AND FORM OF VOTING INSTRUCTION CARD","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-17-012788:f6k113017ex99-2_biondvax.htm","_score":21.933186,"_source":{"ciks":["0001611747"],"period_ending":"2017-11-30","file_num":["001-37353"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":3,"root_forms":["6-K"],"file_date":"2017-11-30","biz_states":["L3"],"sics":["2836"],"form":"6-K","adsh":"0001213900-17-012788","film_num":["171231301"],"biz_locations":["Nes-ziona, L3"],"file_type":"EX-99.2","file_description":"BIONDVAX PHARMACEUTICALS LTD. UNAUDITED FINANCIAL STATEMENTS FOR THE PERIOD ENDED SEPTEMBER 30, 2017","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-23-036129:ea177973ex99-1_biondvax.htm","_score":21.689629,"_source":{"ciks":["0001611747"],"period_ending":"2023-05-04","file_num":["001-37353"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":2,"root_forms":["8-K"],"file_date":"2023-05-04","biz_states":["L3"],"sics":["2836"],"form":"8-K","adsh":"0001213900-23-036129","film_num":["23886848"],"biz_locations":["Jerusalem, L3"],"file_type":"EX-99.1","file_description":"INVESTOR PRESENTATION DATED MAY 4, 2023","inc_states":["L3"],"items":["7.01","9.01"]}},{"_index":"edgar_file","_id":"0001213900-20-024662:ea126269ex99-1_biondvax.htm","_score":21.283852,"_source":{"ciks":["0001611747"],"period_ending":"2020-09-01","file_num":["001-37353"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":2,"root_forms":["6-K"],"file_date":"2020-09-01","biz_states":["L3"],"sics":["2836"],"form":"6-K","adsh":"0001213900-20-024662","film_num":["201153272"],"biz_locations":["Nes-ziona, L3"],"file_type":"EX-99.1","file_description":"CORPORATE PRESENTATION","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-21-045056:ea146517ex99-2_biondvax.htm","_score":21.230667,"_source":{"ciks":["0001611747"],"period_ending":"2021-08-26","file_num":["001-37353"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":3,"root_forms":["6-K"],"file_date":"2021-08-26","biz_states":["L3"],"sics":["2836"],"form":"6-K","adsh":"0001213900-21-045056","film_num":["211212775"],"biz_locations":["Jerusalem, L3"],"file_type":"EX-99.2","file_description":"BIONDVAX PHARMACEUTICALS LTD. UNAUDITED INTERIM FINANCIAL STATEMENTS FOR THE PERIOD ENDING JUNE 30, 2021","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-23-054358:ea181326ex99-1_biondvax.htm","_score":21.230667,"_source":{"ciks":["0001611747"],"period_ending":"2023-07-05","file_num":["001-37353"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":2,"root_forms":["6-K"],"file_date":"2023-07-05","biz_states":["L3"],"sics":["2836"],"form":"6-K","adsh":"0001213900-23-054358","film_num":["231066865"],"biz_locations":["Jerusalem, L3"],"file_type":"EX-99.1","file_description":"BIONDVAX PRESENTATION DATED JULY 2023","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-24-004354:ea191801ex99-1_scinaiimmun.htm","_score":21.20235,"_source":{"ciks":["0001611747"],"period_ending":"2024-01-18","file_num":["001-37353"],"display_names":["Scinai Immunotherapeutics Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":2,"root_forms":["6-K"],"file_date":"2024-01-18","biz_states":["L3"],"sics":["2836"],"form":"6-K","adsh":"0001213900-24-004354","film_num":["24540760"],"biz_locations":["Jerusalem, L3"],"file_type":"EX-99.1","file_description":"SCINAI IMMUNOTHERAPEUTICS PRESENTATION DATED JANUARY 2024","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-24-002051:ea191375ex99-1_scinaiimmun.htm","_score":21.149157,"_source":{"ciks":["0001611747"],"period_ending":"2024-01-09","file_num":["001-37353"],"display_names":["Scinai Immunotherapeutics Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":2,"root_forms":["6-K"],"file_date":"2024-01-09","biz_states":["L3"],"sics":["2836"],"form":"6-K","adsh":"0001213900-24-002051","film_num":["24521812"],"biz_locations":["Jerusalem, L3"],"file_type":"EX-99.1","file_description":"SCINAI IMMUNOTHERAPEUTICS PRESENTATION DATED JANUARY 2024","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-14-008070:filename8.htm","_score":20.75395,"_source":{"ciks":["0001611747"],"period_ending":null,"file_num":["377-00848"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":8,"root_forms":["DRS"],"file_date":"2014-11-13","biz_states":["L3"],"sics":["2836"],"form":"DRS","adsh":"0001213900-14-008070","film_num":["141219428"],"biz_locations":["Nes-ziona, L3"],"file_type":"EX-10.5","file_description":null,"inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-21-063101:ea151533ex99-2_biondvax.htm","_score":20.720976,"_source":{"ciks":["0001611747"],"period_ending":"2021-12-02","file_num":["001-37353"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":3,"root_forms":["6-K"],"file_date":"2021-12-02","biz_states":["L3"],"sics":["2836"],"form":"6-K","adsh":"0001213900-21-063101","film_num":["211466776"],"biz_locations":["Jerusalem, L3"],"file_type":"EX-99.2","file_description":"BIONDVAX PHARMACEUTICALS LTD. UNAUDITED INTERIM FINANCIAL STATEMENTS FOR THE PERIOD ENDING SEPTEMBER 30, 2021","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-14-009164:drs2014ex10v_biondvax.htm","_score":20.669062,"_source":{"ciks":["0001611747"],"period_ending":null,"file_num":["333-201283"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":8,"root_forms":["F-1"],"file_date":"2014-12-29","biz_states":["L3"],"sics":["2836"],"form":"F-1","adsh":"0001213900-14-009164","film_num":["141313416"],"biz_locations":["Nes-ziona, L3"],"file_type":"EX-10.5","file_description":"MANAGEMENT SERVICES AGREEMENT","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-19-009772:f6k053019ex99-2_biondvax.htm","_score":20.359951,"_source":{"ciks":["0001611747"],"period_ending":"2019-05-30","file_num":["001-37353"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":3,"root_forms":["6-K"],"file_date":"2019-05-30","biz_states":["L3"],"sics":["2836"],"form":"6-K","adsh":"0001213900-19-009772","film_num":["19864883"],"biz_locations":["Nes-ziona, L3"],"file_type":"EX-99.2","file_description":"BIONDVAX PHARMACEUTICALS LTD. UNAUDITED FINANCIAL STATEMENTS FOR THE PERIOD ENDED MARCH 31, 2019","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-22-079815:ea170090-f1a2_biondvax.htm","_score":20.355986,"_source":{"ciks":["0001611747"],"period_ending":null,"file_num":["333-267648"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":1,"root_forms":["F-1"],"file_date":"2022-12-14","biz_states":["L3"],"sics":["2836"],"form":"F-1/A","adsh":"0001213900-22-079815","film_num":["221462719"],"biz_locations":["Jerusalem, L3"],"file_type":"F-1/A","file_description":"AMENDMENT NO. 2 TO FORM F-1","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-21-067430:ea153034ex99-2_biondvax.htm","_score":20.270958,"_source":{"ciks":["0001611747"],"period_ending":"2021-09-30","file_num":["001-37353"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":2,"root_forms":["6-K"],"file_date":"2021-12-27","biz_states":["L3"],"sics":["2836"],"form":"6-K/A","adsh":"0001213900-21-067430","film_num":["211518828"],"biz_locations":["Jerusalem, L3"],"file_type":"EX-99.2","file_description":"INTERIM FINANCIAL STATEMENTS AS OF SEPTEMBER 30, 2021","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-19-005921:f6k040819ex99-1_biondvax.htm","_score":20.080654,"_source":{"ciks":["0001611747"],"period_ending":"2018-04-08","file_num":["001-37353"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":2,"root_forms":["6-K"],"file_date":"2019-04-08","biz_states":["L3"],"sics":["2836"],"form":"6-K","adsh":"0001213900-19-005921","film_num":["19736368"],"biz_locations":["Nes-ziona, L3"],"file_type":"EX-99.1","file_description":"COMPANY'S PRESENTATION ON THE PHASE 3 UNIVERSAL FLU VACCINE, DATED APRIL 2, 2019","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-24-052622:ea020782801ex99-1_scinai.htm","_score":19.368282,"_source":{"ciks":["0001611747"],"period_ending":"2024-06-14","file_num":["001-37353"],"display_names":["Scinai Immunotherapeutics Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":2,"root_forms":["6-K"],"file_date":"2024-06-14","biz_states":["L3"],"sics":["2836"],"form":"6-K","adsh":"0001213900-24-052622","film_num":["241043148"],"biz_locations":["Jerusalem, L3"],"file_type":"EX-99.1","file_description":"SCINAI IMMUNOTHERAPEUTICS PRESENTATION DATED JUNE 2024","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-24-036188:ea020465301ex99-1_scinai.htm","_score":19.33269,"_source":{"ciks":["0001611747"],"period_ending":"2024-04-25","file_num":["001-37353"],"display_names":["Scinai Immunotherapeutics Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":2,"root_forms":["6-K"],"file_date":"2024-04-25","biz_states":["L3"],"sics":["2836"],"form":"6-K","adsh":"0001213900-24-036188","film_num":["24876025"],"biz_locations":["Jerusalem, L3"],"file_type":"EX-99.1","file_description":"SCINAI IMMUNOTHERAPEUTICS PRESENTATION DATED APRIL 2024","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-18-002211:f6k022218aex99-1_biondvax.htm","_score":18.363676,"_source":{"ciks":["0001611747"],"period_ending":"2018-02-22","file_num":["001-37353"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":2,"root_forms":["6-K"],"file_date":"2018-02-22","biz_states":["L3"],"sics":["2836"],"form":"6-K","adsh":"0001213900-18-002211","film_num":["18632482"],"biz_locations":["Nes-ziona, L3"],"file_type":"EX-99.1","file_description":"NOTICE AND PROXY STATEMENT WITH RESPECT TO THE COMPANY'S ANNUAL AND EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-23-030228:f10k2022_biondvax.htm","_score":17.285751,"_source":{"ciks":["0001611747"],"period_ending":"2022-12-31","file_num":["001-37353"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":1,"root_forms":["10-K"],"file_date":"2023-04-17","biz_states":["L3"],"sics":["2836"],"form":"10-K","adsh":"0001213900-23-030228","film_num":["23824012"],"biz_locations":["Jerusalem, L3"],"file_type":"10-K","file_description":"ANNUAL REPORT","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-16-016532:f6k082916a1ex99i_biondvax.htm","_score":16.94761,"_source":{"ciks":["0001611747"],"period_ending":"2016-08-29","file_num":["001-37353"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":2,"root_forms":["6-K"],"file_date":"2016-09-01","biz_states":["L3"],"sics":["2836"],"form":"6-K/A","adsh":"0001213900-16-016532","film_num":["161865872"],"biz_locations":["Nes-ziona, L3"],"file_type":"EX-99.1","file_description":"AMENDED NOTICE AND PROXY STATEMENT, DATED AUGUST 29, 2016","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-16-016212:f6k081816aex99i_biondvax.htm","_score":16.87492,"_source":{"ciks":["0001611747"],"period_ending":"2016-08-18","file_num":["001-37353"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":2,"root_forms":["6-K"],"file_date":"2016-08-18","biz_states":["L3"],"sics":["2836"],"form":"6-K","adsh":"0001213900-16-016212","film_num":["161841385"],"biz_locations":["Nes-ziona, L3"],"file_type":"EX-99.1","file_description":"NOTICE AND PROXY STATEMENT, DATED AUGUST 18, 2016","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-16-016625:f6k090816a1ex99i_biondvax.htm","_score":16.566757,"_source":{"ciks":["0001611747"],"period_ending":"2016-09-08","file_num":["001-37353"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":2,"root_forms":["6-K"],"file_date":"2016-09-08","biz_states":["L3"],"sics":["2836"],"form":"6-K/A","adsh":"0001213900-16-016625","film_num":["161876228"],"biz_locations":["Nes-ziona, L3"],"file_type":"EX-99.1","file_description":"AMENDED NOTICE AND PROXY STATEMENT, DATED SEPTEMBER 8, 2016","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-23-068963:ea183844-f3_biondvaxpharma.htm","_score":16.470587,"_source":{"ciks":["0001611747"],"period_ending":null,"file_num":["333-274078"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":1,"root_forms":["F-3"],"file_date":"2023-08-18","biz_states":["L3"],"sics":["2836"],"form":"F-3","adsh":"0001213900-23-068963","film_num":["231186061"],"biz_locations":["Jerusalem, L3"],"file_type":"F-3","file_description":"REGISTRATION STATEMENT","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-16-016700:f6k091216bex99i_biondvax.htm","_score":15.832314,"_source":{"ciks":["0001611747"],"period_ending":"2016-09-12","file_num":["001-37353"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":2,"root_forms":["6-K"],"file_date":"2016-09-12","biz_states":["L3"],"sics":["2836"],"form":"6-K","adsh":"0001213900-16-016700","film_num":["161881070"],"biz_locations":["Nes-ziona, L3"],"file_type":"EX-99.1","file_description":"POSITION NOTICE DATED SEPTEMBER 6, 2016","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-20-019099:ea124627-f3_biondvaxpharma.htm","_score":15.587351,"_source":{"ciks":["0001611747"],"period_ending":null,"file_num":["333-240189"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":1,"root_forms":["F-3"],"file_date":"2020-07-29","biz_states":["L3"],"sics":["2836"],"form":"F-3","adsh":"0001213900-20-019099","film_num":["201060324"],"biz_locations":["Nes-ziona, L3"],"file_type":"F-3","file_description":"REGISTRATION STATEMENT","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-22-059914:ea166443-f1_biondvax.htm","_score":15.18091,"_source":{"ciks":["0001611747"],"period_ending":null,"file_num":["333-267648"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":1,"root_forms":["F-1"],"file_date":"2022-09-29","biz_states":["L3"],"sics":["2836"],"form":"F-1","adsh":"0001213900-22-059914","film_num":["221277918"],"biz_locations":["Jerusalem, L3"],"file_type":"F-1","file_description":"REGISTRATION STATEMENT","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-14-008070:filename5.htm","_score":14.646242,"_source":{"ciks":["0001611747"],"period_ending":null,"file_num":["377-00848"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":5,"root_forms":["DRS"],"file_date":"2014-11-13","biz_states":["L3"],"sics":["2836"],"form":"DRS","adsh":"0001213900-14-008070","film_num":["141219428"],"biz_locations":["Nes-ziona, L3"],"file_type":"EX-10.2","file_description":null,"inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-14-009164:drs2014ex10ii_biondvax.htm","_score":14.527138,"_source":{"ciks":["0001611747"],"period_ending":null,"file_num":["333-201283"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":5,"root_forms":["F-1"],"file_date":"2014-12-29","biz_states":["L3"],"sics":["2836"],"form":"F-1","adsh":"0001213900-14-009164","film_num":["141313416"],"biz_locations":["Nes-ziona, L3"],"file_type":"EX-10.2","file_description":"EXECUTION COPY","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-18-005179:f20f2017_biondvaxpharma.htm","_score":14.519999,"_source":{"ciks":["0001611747"],"period_ending":"2017-12-31","file_num":["001-37353"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":1,"root_forms":["20-F"],"file_date":"2018-04-30","biz_states":["L3"],"sics":["2836"],"form":"20-F","adsh":"0001213900-18-005179","film_num":["18790117"],"biz_locations":["Nes-ziona, L3"],"file_type":"20-F","file_description":"ANNUAL REPORT","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-19-004755:ff12019_biondvaxpharma.htm","_score":14.345316,"_source":{"ciks":["0001611747"],"period_ending":null,"file_num":["333-230484"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":1,"root_forms":["F-1"],"file_date":"2019-03-25","biz_states":["L3"],"sics":["2836"],"form":"F-1","adsh":"0001213900-19-004755","film_num":["19702752"],"biz_locations":["Nes-ziona, L3"],"file_type":"F-1","file_description":"REGISTRATION STATEMENT","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-23-081572:ea187455-f1_scinai.htm","_score":14.157597,"_source":{"ciks":["0001611747"],"period_ending":null,"file_num":["333-275217"],"display_names":["Scinai Immunotherapeutics Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":1,"root_forms":["F-1"],"file_date":"2023-10-30","biz_states":["L3"],"sics":["2836"],"form":"F-1","adsh":"0001213900-23-081572","film_num":["231361144"],"biz_locations":["Jerusalem, L3"],"file_type":"F-1","file_description":"REGISTRATION STATEMENT","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-16-012814:f20f2015_biondvaxpharma.htm","_score":13.673449,"_source":{"ciks":["0001611747"],"period_ending":"2015-12-31","file_num":["001-37353"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":1,"root_forms":["20-F"],"file_date":"2016-04-27","biz_states":["L3"],"sics":["2836"],"form":"20-F","adsh":"0001213900-16-012814","film_num":["161596055"],"biz_locations":["Nes-ziona, L3"],"file_type":"20-F","file_description":"ANNUAL AND TRANSITION REPORT OF FOREIGN PRIVATE ISSUERS","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-15-002471:ff12014a1_biondvax.htm","_score":13.597036,"_source":{"ciks":["0001611747"],"period_ending":null,"file_num":["333-201283"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":1,"root_forms":["F-1"],"file_date":"2015-04-06","biz_states":["L3"],"sics":["2836"],"form":"F-1/A","adsh":"0001213900-15-002471","film_num":["15752966"],"biz_locations":["Nes-ziona, L3"],"file_type":"F-1/A","file_description":"AMENDED REGISTRATION STATEMENT","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-24-007939:ea192382-f3_scinaiimmun.htm","_score":13.30316,"_source":{"ciks":["0001611747"],"period_ending":null,"file_num":["333-276767"],"display_names":["Scinai Immunotherapeutics Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":1,"root_forms":["F-3"],"file_date":"2024-01-30","biz_states":["L3"],"sics":["2836"],"form":"F-3","adsh":"0001213900-24-007939","film_num":["24578424"],"biz_locations":["Jerusalem, L3"],"file_type":"F-3","file_description":"REGISTRATION STATEMENT","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-19-007852:ff12019a1_biondvaxpharma.htm","_score":13.207186,"_source":{"ciks":["0001611747"],"period_ending":null,"file_num":["333-230484"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":1,"root_forms":["F-1"],"file_date":"2019-05-06","biz_states":["L3"],"sics":["2836"],"form":"F-1/A","adsh":"0001213900-19-007852","film_num":["19798286"],"biz_locations":["Nes-ziona, L3"],"file_type":"F-1/A","file_description":"AMENDMENT NO. 1 TO FORM F-1/A","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-19-009767:ff12019a2_biondvaxpharma.htm","_score":13.125792,"_source":{"ciks":["0001611747"],"period_ending":null,"file_num":["333-230484"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":1,"root_forms":["F-1"],"file_date":"2019-05-30","biz_states":["L3"],"sics":["2836"],"form":"F-1/A","adsh":"0001213900-19-009767","film_num":["19864686"],"biz_locations":["Nes-ziona, L3"],"file_type":"F-1/A","file_description":"AMENDMENT NO. 2 TO REGISTRATION STATEMENT","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-24-087739:ea021750801ex99-1_scinai.htm","_score":13.057007,"_source":{"ciks":["0001611747"],"period_ending":"2024-10-15","file_num":["001-37353"],"display_names":["Scinai Immunotherapeutics Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":"2","root_forms":["6-K"],"file_date":"2024-10-15","biz_states":["L3"],"sics":["2836"],"form":"6-K","adsh":"0001213900-24-087739","film_num":["241371617"],"biz_locations":["Jerusalem, L3"],"file_type":"EX-99.1","file_description":"NOTICE AND PROXY STATEMENT OF ANNUAL MEETING OF SHAREHOLDERS.","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-19-010278:ff12019a4_biondvaxpharma.htm","_score":12.870367,"_source":{"ciks":["0001611747"],"period_ending":null,"file_num":["333-230484"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":1,"root_forms":["F-1"],"file_date":"2019-06-07","biz_states":["L3"],"sics":["2836"],"form":"F-1/A","adsh":"0001213900-19-010278","film_num":["19884670"],"biz_locations":["Nes-ziona, L3"],"file_type":"F-1/A","file_description":"AMENDMENT NO. 4 TO FORM F-1","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-15-002528:ff12014a2_biondvax.htm","_score":12.720362,"_source":{"ciks":["0001611747"],"period_ending":null,"file_num":["333-201283"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":1,"root_forms":["F-1"],"file_date":"2015-04-08","biz_states":["L3"],"sics":["2836"],"form":"F-1/A","adsh":"0001213900-15-002528","film_num":["15758654"],"biz_locations":["Nes-ziona, L3"],"file_type":"F-1/A","file_description":"AMENDED REGISTRATION STATEMENT","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-15-003330:ff12015a5_biondvax.htm","_score":12.586981,"_source":{"ciks":["0001611747"],"period_ending":null,"file_num":["333-201283"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":1,"root_forms":["F-1"],"file_date":"2015-05-06","biz_states":["L3"],"sics":["2836"],"form":"F-1/A","adsh":"0001213900-15-003330","film_num":["15838201"],"biz_locations":["Nes-ziona, L3"],"file_type":"F-1/A","file_description":"AMENDED REGISTRATION STATEMENT","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-25-089916:ea0258179-f1_scinai.htm","_score":12.530382,"_source":{"ciks":["0001611747"],"period_ending":null,"file_num":["333-290437"],"display_names":["Scinai Immunotherapeutics Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":1,"root_forms":["F-1"],"file_date":"2025-09-22","biz_states":["L3"],"sics":["2836"],"form":"F-1","adsh":"0001213900-25-089916","film_num":["251328963"],"biz_locations":["Jerusalem, L3"],"file_type":"F-1","file_description":"REGISTRATION STATEMENT","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-15-003055:ff1a_biondvax.htm","_score":12.51786,"_source":{"ciks":["0001611747"],"period_ending":null,"file_num":["333-201283"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":1,"root_forms":["F-1"],"file_date":"2015-04-28","biz_states":["L3"],"sics":["2836"],"form":"F-1/A","adsh":"0001213900-15-003055","film_num":["15797804"],"biz_locations":["Nes-ziona, L3"],"file_type":"F-1/A","file_description":null,"inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-16-010328:posam1_biondvax.htm","_score":12.471165,"_source":{"ciks":["0001611747"],"period_ending":null,"file_num":["333-201283"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":1,"root_forms":["POS AM"],"file_date":"2016-01-22","biz_states":["L3"],"sics":["2836"],"form":"POS AM","adsh":"0001213900-16-010328","film_num":["161354734"],"biz_locations":["Nes-ziona, L3"],"file_type":"POS AM","file_description":null,"inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-19-010133:ff12019a3_biondvaxpharma.htm","_score":12.328123,"_source":{"ciks":["0001611747"],"period_ending":null,"file_num":["333-230484"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":1,"root_forms":["F-1"],"file_date":"2019-06-06","biz_states":["L3"],"sics":["2836"],"form":"F-1/A","adsh":"0001213900-19-010133","film_num":["19881221"],"biz_locations":["Nes-ziona, L3"],"file_type":"F-1/A","file_description":"AMENDMENT NO. 3 TO FORM F-1","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-16-010574:f424b4020216_biondvax.htm","_score":12.263399,"_source":{"ciks":["0001611747"],"period_ending":null,"file_num":["333-201283"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":1,"root_forms":["424B4"],"file_date":"2016-02-03","biz_states":["L3"],"sics":["2836"],"form":"424B4","adsh":"0001213900-16-010574","film_num":["161384996"],"biz_locations":["Nes-ziona, L3"],"file_type":"424B4","file_description":"PROSPECTUS","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-15-003603:f424a050715_biondvax.htm","_score":12.143442,"_source":{"ciks":["0001611747"],"period_ending":null,"file_num":["333-201283"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":1,"root_forms":["424B4"],"file_date":"2015-05-13","biz_states":["L3"],"sics":["2836"],"form":"424B4","adsh":"0001213900-15-003603","film_num":["15859435"],"biz_locations":["Nes-ziona, L3"],"file_type":"424B4","file_description":"PROSPECTUS","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-19-007348:f20f2018_biondvaxpharma.htm","_score":12.098425,"_source":{"ciks":["0001611747"],"period_ending":"2018-12-31","file_num":["001-37353"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":1,"root_forms":["20-F"],"file_date":"2019-04-30","biz_states":["L3"],"sics":["2836"],"form":"20-F","adsh":"0001213900-19-007348","film_num":["19778279"],"biz_locations":["Nes-ziona, L3"],"file_type":"20-F","file_description":"ANNUAL REPORT","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-15-003350:f424a050715_biondvax.htm","_score":11.83601,"_source":{"ciks":["0001611747"],"period_ending":null,"file_num":["333-201283"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":1,"root_forms":["424A"],"file_date":"2015-05-07","biz_states":["L3"],"sics":["2836"],"form":"424A","adsh":"0001213900-15-003350","film_num":["15840180"],"biz_locations":["Nes-ziona, L3"],"file_type":"424A","file_description":"PROSPECTUS","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-17-000676:posam2016a2_biondvax.htm","_score":11.556976,"_source":{"ciks":["0001611747"],"period_ending":null,"file_num":["333-201283"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":1,"root_forms":["POS AM"],"file_date":"2017-01-26","biz_states":["L3"],"sics":["2836"],"form":"POS AM","adsh":"0001213900-17-000676","film_num":["17548019"],"biz_locations":["Nes-ziona, L3"],"file_type":"POS AM","file_description":"POST-EFFECTIVE AMENDMENT NO. 2 TO FORM F-1","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-17-000816:posam2016a3_biondvax.htm","_score":11.379778,"_source":{"ciks":["0001611747"],"period_ending":null,"file_num":["333-201283"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":1,"root_forms":["POS AM"],"file_date":"2017-01-31","biz_states":["L3"],"sics":["2836"],"form":"POS AM","adsh":"0001213900-17-000816","film_num":["17561877"],"biz_locations":["Nes-ziona, L3"],"file_type":"POS AM","file_description":"AMENDED REGISTRATION STATEMENT","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-22-079174:ea170014-f1a1_biondvax.htm","_score":11.272503,"_source":{"ciks":["0001611747"],"period_ending":null,"file_num":["333-267648"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":1,"root_forms":["F-1"],"file_date":"2022-12-12","biz_states":["L3"],"sics":["2836"],"form":"F-1/A","adsh":"0001213900-22-079174","film_num":["221457957"],"biz_locations":["Jerusalem, L3"],"file_type":"F-1/A","file_description":"AMENDMENT NO. 1 TO FORM F-1","inc_states":["L3"],"items":[]}},{"_index":"edgar_file","_id":"0001213900-16-017974:ff32016_biondvaxpharma.htm","_score":11.007238,"_source":{"ciks":["0001611747"],"period_ending":null,"file_num":["333-214439"],"display_names":["BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)"],"xsl":null,"sequence":1,"root_forms":["F-3"],"file_date":"2016-11-04","biz_states":["L3"],"sics":["2836"],"form":"F-3","adsh":"0001213900-16-017974","film_num":["161974096"],"biz_locations":["Nes-ziona, L3"],"file_type":"F-3","file_description":"REGISTRATION STATEMENT FOR SPECIFIED TRANSACTIONS","inc_states":["L3"],"items":[]}}]},"aggregations":{"entity_filter":{"doc_count_error_upper_bound":0,"sum_other_doc_count":0,"buckets":[{"key":"BiondVax Pharmaceuticals Ltd.  (SCNI)  (CIK 0001611747)","doc_count":97},{"key":"Scinai Immunotherapeutics Ltd.  (SCNI)  (CIK 0001611747)","doc_count":23},{"key":"FIDELITY CONCORD STREET TRUST  (CIK 0000819118)","doc_count":2},{"key":"Rotman Avner  (CIK 0001960174)","doc_count":2},{"key":"SPDR INDEX SHARES FUNDS  (CIK 0001168164)","doc_count":2},{"key":"Ark ETF Trust  (CIK 0001579982)","doc_count":1},{"key":"BANK OF NEW YORK / ADR DIVISION  (CIK 0001201935)","doc_count":1},{"key":"IZUN PHARMACEUTICALS CORP  (CIK 0001406071)","doc_count":1},{"key":"TRUST FOR PROFESSIONAL MANAGERS  (CIK 0001141819)","doc_count":1}]},"sic_filter":{"doc_count_error_upper_bound":0,"sum_other_doc_count":0,"buckets":[{"key":"2836","doc_count":120},{"key":"8880","doc_count":1}]},"biz_states_filter":{"doc_count_error_upper_bound":0,"sum_other_doc_count":0,"buckets":[{"key":"L3","doc_count":121},{"key":"MA","doc_count":4},{"key":"NY","doc_count":2},{"key":"WI","doc_count":1}]},"form_filter":{"doc_count_error_upper_bound":0,"sum_other_doc_count":0,"buckets":[{"key":"6-K","doc_count":55},{"key":"F-1","doc_count":24},{"key":"20-F","doc_count":10},{"key":"F-3","doc_count":6},{"key":"N-PX","doc_count":6},{"key":"POS AM","doc_count":6},{"key":"424B4","doc_count":4},{"key":"D","doc_count":3},{"key":"DRS","doc_count":3},{"key":"S-8","doc_count":3},{"key":"3","doc_count":2},{"key":"10-K","doc_count":1},{"key":"424A","doc_count":1},{"key":"424B3","doc_count":1},{"key":"8-K","doc_count":1},{"key":"F-6","doc_count":1}]}},"query":{"_source":{"exclude":["doc_text"]},"query":{"bool":{"must":[{"match_phrase":{"doc_text":"Avner Rotman"}}],"must_not":[],"should":[],"filter":[]}},"from":0,"size":100,"aggregations":{"form_filter":{"terms":{"field":"root_forms","size":30}},"entity_filter":{"terms":{"field":"display_names.raw","size":30}},"sic_filter":{"terms":{"field":"sics","size":30}},"biz_states_filter":{"terms":{"field":"biz_states","size":30}}}}}